Hudson Bay Capital Management’s NLS Pharmaceutics Ltd. Warrant NLSPW Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q1 | – | Sell |
-71,356
| Closed | -$821 | – | 1002 |
|
2024
Q4 | $821 | Hold |
71,356
| – | – | ﹤0.01% | 690 |
|
2024
Q3 | $1.11K | Sell |
71,356
-28,644
| -29% | -$444 | ﹤0.01% | 624 |
|
2024
Q2 | $3.01K | Hold |
100,000
| – | – | ﹤0.01% | 618 |
|
2024
Q1 | $4.9K | Hold |
100,000
| – | – | ﹤0.01% | 580 |
|
2023
Q4 | $5.61K | Hold |
100,000
| – | – | ﹤0.01% | 565 |
|
2023
Q3 | $10.5K | Hold |
100,000
| – | – | ﹤0.01% | 624 |
|
2023
Q2 | $10.2K | Hold |
100,000
| – | – | ﹤0.01% | 675 |
|
2023
Q1 | $15K | Hold |
100,000
| – | – | ﹤0.01% | 704 |
|
2022
Q4 | $27.7K | Hold |
100,000
| – | – | ﹤0.01% | 753 |
|
2022
Q3 | $25K | Hold |
100,000
| – | – | ﹤0.01% | 985 |
|
2022
Q2 | $12K | Hold |
100,000
| – | – | ﹤0.01% | 1167 |
|
2022
Q1 | $38K | Sell |
100,000
-100,000
| -50% | -$38K | ﹤0.01% | 1011 |
|
2021
Q4 | $165K | Hold |
200,000
| – | – | ﹤0.01% | 896 |
|
2021
Q3 | $154K | Hold |
200,000
| – | – | ﹤0.01% | 856 |
|
2021
Q2 | $192K | Hold |
200,000
| – | – | ﹤0.01% | 827 |
|
2021
Q1 | $190K | Buy |
+200,000
| New | +$190K | ﹤0.01% | 768 |
|